Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.
Founded last year, the target company focuses on epigenetic modification, which is a natural and heritable gene regulation mechanism that doesn’t alter the body’s underlying DNA. The goal is to harness...
Japanese healthcare technology start-up Ubie has closed its Series C round on JPY6.3bn (USD 43.2m) with the latest tranche featuring PE-owned pharmacy chain operator Sogo Medical.
Specialist food and agriculture investor Proterra Investment Partners has agreed to invest in Aperion Bioenergy, a Singapore-based bioenergy producer that sources used cooking oil for feedstocks.
Dymon Asia Private Equity (DAPE) has closed its third Southeast Asia middle market private equity fund at a hard cap of USD 650m, beating a target of USD 550m.
Gamurs, a Sydney-headquartered media company specialising in gaming, e-sports, and entertainment, has secured USD 12m in Series A funding.